info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anemia Drugs Companies

Several pharmaceutical companies were actively involved in the development, manufacturing, and distribution of drugs for the treatment of anemia. Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin, leading to reduced oxygen-carrying capacity in the blood. 

Anemia Drugs Companies


Latest Anemia Drugs Companies Update:

InSilico Medicine announced a breakthrough AI-driven discovery of a novel PHD inhibitor for anemia treatment. This potentially offers a new approach to targeting the underlying cause of anemia, particularly in cases where existing medications aren't effective. (October 26, 2023)


GSK's Jesduvroq (daprodustat) continues to gain traction as a novel anemia treatment for kidney disease patients. Approved in February 2023, this drug offers an alternative to erythropoiesis-stimulating agents (ESAs) and is already seeing adoption in some markets. (November 7, 2023)


No major M&A deals involving major anemia drug companies have been announced recently. However, smaller players in the field are actively acquiring technologies and expanding their portfolios. For example, Cygnus Technologies' acquisition of SiNica Bio strengthens their presence in the Asian HCP testing market, which can indirectly impact anemia drug development.


List of Anemia Drugs Key companies in the market

  • Amgen Inc 

  • GlaxoSmithKline plc 

  • Bluebird bio 

  • Biocon 

  • GlycoMimetics Inc 

  • Regen biopharma Inc 

  • Bayer AG 

  • Acceleron Pharma 

  • Eli Lilly and company



 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.